Carcinogenesis of the ethmoidal adenocarcinoma due to wood dust;La carcinogenèse de l'adénocarcinome de l'ethmoïde aux poussières de bois

Revue de Laryngologie Otologie Rhinologie

Volumn 130, Issue 2, 2009, Pages 93-104

  De Gabory, L ^a,b   Conso, F ^a,c   Barry, B ^a,d   Stoll, D ^a,b  

^a Clinique Universitaire d'Orl et Chirurgie Cervico Faciale ^*

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c BICHAT HOSPITAL   (France)

^d HÔPITAL PELLEGRIN   (France)

Author keywords

Adenocarcinoma; Ethmoid sinus; Sinus cancer; Wood dust; Woodworker

Indexed keywords

CARCINOGEN; CYTOKERATIN 20; CYTOKERATIN 7; DIPEPTIDYL CARBOXYPEPTIDASE; K RAS PROTEIN; KI 67 ANTIGEN; TRANSCRIPTION FACTOR CDX2;

CANCER RISK; CARCINOGENESIS; CARPENTER; CHROMOSOMAL INSTABILITY; COLON ADENOCARCINOMA; ETHMOID ADENOCARCINOMA; ETHMOID SINUS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; PARANASAL SINUS CARCINOMA; REVIEW; SYSTEMATIC REVIEW; WOOD DUST;

ADENOCARCINOMA; DUST; ETHMOID SINUS; EVIDENCE-BASED MEDICINE; HUMANS; OCCUPATIONAL DISEASES; PARANASAL SINUS NEOPLASMS; RISK; WOOD;

EID: 70349510198     PISSN: 00351334     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (110)

1. STOLL D, BÉBÉAR JP, TRUILHÉ Y, DARROUZET V, DAVID N. Les adénocarcinomes de l'ethmoïde : étude rétrospective de 76 patients. REV LARYNGOL OTOL RHINOL. 2001;122:21-24.
2. CHOUSSY O, FERRON C, VÉDRINE PO, TOUSSAINT B, LIÉTIN B, MARANDAS P, BABIN E, DE RAUCOURT D, REYT E, COSMIDIS A, MAKEIFF M, DEHESDIN D, GETTEC STUDY GROUP. Adenocarcinoma of ethmoid: A GETTEC retrospective multicenter study of 418 cases. LARYNGOSCOPE. 2008 Mar; 118(3):437-443
3. KAUPPINEN T, VINCENT R, LIUKKONEN T, GRZEBYK M, KAUPPINEN A, WELLING I, AREZES P, et al. Occupational exposure to inhalable wood dust in the member states of the European Union. ANN OCCUP HYG. 2006 Aug;50(6):549-561
4. RODRIGUEZ J. Stratégie de dépistage des cancers ORL dus aux poussières de bois. IVème journée de recherche en médecine du travail. Arch Mal Prof. 1998;59(3):176-180.
5. IMBERNON E. Estimation du nombre de cas de certains cancers attribuables à des facteurs professionnels en France. Département santé travail-Institut de Veille sanitaire. 2003:28.
6. KEYHANI K, SCHERER PW, MOZELL MM. Numerical simulation of airflow in the human nasal cavity. J BIOMECH ENG 1995;117:253-263.
7. CHOMETON F, EBBO D, GILLIERON P, KOÏFMAN P, LECOMTE F, SORREL-DEJERINE N. Simulation numérique de l'écoulement de l'air dans les fosses nasales. ANN OTOLARYNGOL CHIR CERVICOFAC. 2000;117(2):98-104.
8. ISHIKAWA S, NAKAYAMA T, WATANABE M, MATZUSAWA T. Visualization of flow resistance in physiological nasal respiration: Analysis of velocity and vorticities using numeral simulation. ARCH OTOLARYNGOL HEAD NECK SURG. 2006;132:1203-1209.
9. HOUNAM RF, BLACK A, WALSH L. The deposition of aerosol particles in the nasopharyngeal region of the human respiratory tract. J AEROSOL SCI. 1971;2:47-61.
10. GIACOMELLI-MALTONI G, MELANDRI C, PRODI V, TARRONI G. Deposition efficiency of monodisperse particles in human respiratory tract. AM IND HYG ASSOC J. 1972;33:603-610.
11. YAMADA Y, CHENG YS,YEH HC, SWIFT DL. Inspiratory and expiratory deposition of ultrafine particles in a human nasal cast. INHAL TOXICOL. 1988;1:1-17.
12. ITOH H, SMALDONE GC, SWIFT DL, WAGNER HN. Mechanisms of aerosol deposition in a nasal model. J AEROSOL SCI. 1985;16:529-534. (Pubitemid 16227732)
13. HOY N, TAKANO H, HYO Y. Particle deposition efficiency of therapeutic aerosols in the human maxillary sinus. RHINOLOGY. 1989;27(1):17-26.
14. RASMUSSEN TR, ANDERSEN A, PEDERSEN OF. Particle deposition in the nose related to nasal cavity geometry. RHINOLOGY. 2000;38(3):102-107.
15. ZWARTZ GJ, GUILMETTE RA. Effect of flow rate on particle deposition in a replica of a human nasal airway. INHAL TOX 2001;13:109-127.
16. International Commission on Radiological Protection: Human respiratory tract model for radiological protection. ANN ICRP PUBL. 1994;66(24):1-3.
17. JAMES DS, LAMBERT WE, MERMIER CM, STIDLEY CA, CHICK TW, SAMET JM. Oronasal distribution of ventilation at different ages. ARCH ENVIRON HEALTH. 1997;52:118-123.
18. NIINIMAA V, COLE P, MINTZ L. The switching point from oral to oronasal breathing. RESPIR PHYSIOL. 1980;42:61-71.
19. SCHROETER JD, KIMBELL JS, ASGHARIAN B. Analysis of particle deposition in the turbinate and olfactory regions using a human nasal computational fluid dynamics model. J AEROSOL MED 2006;19(3):301-313
20. KECK T, LEIACKER R, KLOTZ M, LINDEMANN J, RIECHELMANN H. Detection of particles within the nasal airways during respiration. EUR ARCH OTORHINOLARYNGOL 2000;257:493-497.
21. KECK T, LEIACKER R, KUHNEMANN S, RETTINGER G, LINDEMANN J. Detection of particles within the nasal airways before and after nasal decongestion. CLIN OTOLARYNGOL ALLIED SCI. 2001;26(4):324-328
22. WHITEHEAD LW, FREUND T, HAHN LL. Suspended dust concentrations and size distributions and quantitative analysis of inorganic particles from woodworking operations. AM IND HYG ASSOC J 1981;42:461-467
23. CHUNG KY, CUTHBERT RJ, REVELL GS, WASSEL SG, SUMMERS N. Astudy on dust emission, particle size distribution and formaldehyde concentration during machining of medium density fibreboard. ANN OCCUP HYG. 2000;44:455-466
24. VINCENT R, JEANDEL B. COLCHIC-occupational exposure to chemical agents database: Current content and development perspectives. APPL OCCUP ENVIRON HYG. 2001;16:115-121
25. NEWMAN SP, MOREN F, CLARKE SW. Deposition pattern of nasal sprays in man. RHINOLOGY. 1988;26(2):111-120
26. WEBER R, KEERL R, RADZIWILL R, SCHICK B, JASPERSEN D, DSHAMBAZOV K, MLYNSKI G, DRAF W. Videoendoscopic analysis of nasal steroid distribution. RHINOLOGY. 2001 Jun;37(2):69-73.
27. HEALD D, BERRIDGE M, MUSWICK G, et al. Nasal biodistribution and pharmacokinetics of an aqueous formulation of triamcinolone acetonide utilizing positron emission tomography (PET). ANN ALLERGY ASTHMA IMMUNOLOGY. 1997;78:96.
28. JEAL W, FAULDS D. Triamcinolone acetonide a review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis. DRUGS. 1997 February;53(2):257-280.
29. PENNINGTON AK, RATCLIFFE JH, WILSON CG, HARDY JG. The influence of solution viscosity on nasal spray deposition and clearance. INTERNATIONAL JOURNAL OF PHARMACEUTICS. 1998;43:221-224.
30. LIPWORTH BJ, JACKSON CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millenium. DRUG SAFETY. 2000;23(1):11-33.
31. CAVE A, ARLETT P, LEE E. Inhaled and nasal corticosteroids: Factors affecting the risks of systemic adverse effects. PHARMACOLOGY AND THERAPEUTICS. 1999 Sept;83:153-179.
32. ALLEN D. Systemic effects of intranasal steroids: An endocrinologist's persperctive. JOURNAL OF ALLERGY, CLINICAL AND IMMUNOLOGY. 2000 Oct;106 suppl,4:179-190.
33. BLACK A, EVANS JC, HADFIELD EH, MACBETH RG, MORGAN A, WALSH M. Impairment of nasal mucociliary clearance in woodworkers in the furniture industry. BR J IND MED. 1974;31:10-17
34. AHMAN M, HOLMSTROM M, CYNKIER I, SODERMAN E. Work related impairment of nasal function in Swedish woodworker teachers. OCCUP ENVIRON MED. 1996;53:112-117
35. JANKOWSKI R, GEORGEL T, VIGNAUD JM, HEMMANOUI B, TOUSSAINT B, GRAFF P, GEOFFROIS L, HENROT P, KAMINSKY MC. Endoscopic surgery reveals that woodworker's adenocarcinomas originate in the olfactory cleft. RHINOLOGY 2007;45(4):308-314.
36. GEORGE B, SALVAN D, LUBOINSKI B, BOISSONNET H, LOT G. Tumeurs malignes de l'ethmoïde. Série homogène de 41 cas opérés par voie mixte. NEUROCHIRURGIE. 1997;43:121-124.
37. MOREAU JJ, BESSÈDE JP, HEURTEBISE F, MOUFID A. Adénocarcinomes de l'ethmoide chez les travailleurs de bois : étude rétrospective de 25 cas. NEUROCHIRURGIE. 1997;43:111-117.
38. URSO C, NINU MB, FRANCHI A, PAGLIERANI M, BONDI R. Intestinal-type adenocarcinoma of the sinonasal tract: A clinico-pathologic study of 18 cases. TUMORI. 1993;79:205-210.
39. NUNEZ F, SUAREZ C, ALVAREZ I, LOSA J, BARTHE P, FRESNO M. Sinonasal adenocarcinoma: Epidemiological and clinico-pathological study of 34 cases. J OTOLARYNGOL 1993;22(2):86-90. (Pubitemid 23165126)
40. ROUX FX, PAGES JC, NATAF F, DEVAUX B, LACCOURREYE O, MENARD M, BRASNU D. Les tumeurs malignes ethmoïdosphénoïdales : cent trente cas ; étude rétrospective. NEURO CHIRURGIE. 1997;43:100-110.
41. JEGOUX F, FERRON CH, MALARD O, CARIOU G, FAURE A, BEAUVILLAIN DE MONTREUIL C. Adénocarcinome de l'ethmoïde : expérience nantaise (80 cas). Place de la résection de la base ducrâne par voie trans-faciale. ANN OTOLARYNGOL CHIR CERVICOFAC. 2004;121(4):213-221
42. LEROUX-ROBERT J. Les cancers de l'ethmoïde chez les travailleurs du bois. CAHIERS D'O.R.L. 1974;9(6):585-593
43. LIÉTIN B, MOM T, AVAN P, et al. Adénocarcinomes de l'ethmoïde : analyse rétrospective des facteurs pronostics. ANN OTO LARYNGOL CHIR CERVICOFAC. 2006;123(5) :211-220
44. SY A, MARANDAS P, HARTL F, et al : Les adénocarcinomes de l'ethmoïde, à propos d'une série de 76 patients traités à l'institut gustave Roussy de 1983 à 1999. In XXXVIème rapport de la société française de carcinologie cervico-faciale : Les tumeurs malignes du massif facial et des cavités naso-sinusiennes. Fontanel JP, Klossek JM. EDK, Paris 2004 :31-40.
45. ROUX FX, BEHM E, PAGE P, LACCOURREYE O, PAGES JC, BRASNU D. Adenocarcinomas of the ethmoid sinuses. Epidemiological data. ANN OTOLARYNGOL CHIR CERVICOFAC. 2002;119(5):271-280
46. NYLANDER LA, DERNENT JM. Carcinogenic effects of wood dust : review and discussion. AM J IND MED. 1993;24:619-1617
47. BIMBI G, SARACENO MS, RICCIO S, et al. Adenocarcinoma of ethmoid sinus: An occupational disease. ACTA OTORHINOLARYNGOL ITAL. 2004;24(4):199-203.
48. DEMERS PA, KOGEVINOS M, BOFFETTA P, LECLERC A, LUCE A, GERIN M, BATTISTA G, BELLI S, BOLM-AUDORF U, BRINTON LA, et al. Wood dust and sino-nasal cancer: Pooled analysis of twelve case-control studies. AM J IND MED 1995;28:151-166
49. MARCUCCILLI A, PERDRIX A, METRAS E, COSTA SALUTE C, GARY Y, SAENZ F, DE GAUDEMARIS R. Evaluation des symptômes et de la fonction respiratoire en relation avec les expositions aux poussières de bois dans les ateliers de menuiseries industrielle. ARCH MAL PROF. 1998;59(5):1250-3274
50. DE GABORY L, STOLL D, DARROUZET V, BÉBÉAR JP. Les adénocarcinomes de l'ethmoïde, étude rétrospective de 76 patients. In XXXVIème Rapport de la société française de carcinologie cervico-faciale : Les tumeurs malignes du massif facial et des cavités naso-sinusiennes. Fontanel JP, Klossek JM. EDK, Paris 2004:41-50.
51. BRASNU D, LACCOURREYE O, BASSOT V, LACCOURREYE L. Cisplatin-based neoadjuvant chemotherapy and combined resection for ethmoid sinus adenocarcinoma reaching and or invading the skull base. ARCH. OTOLARYNGOL HEAD NECK SURG 1996;122:765-768.
52. KRAUS DH, STERMAN BM, LEVINE HL, WOOD B, TUCKER HM, LAVERTU P. Factors influencing survival in ethmoid sinus cancer. ARCH. OTOLARYNGOL. HEAD NECK SURG. 1992;118(4):367-372.
53. LUND VJ, HARRISSON DFN. Craniofacial resection for tumors of the nasal cavity and paranasal sinuses. AM. J. SURG. 1988;156:187-190.
54. MCCUTCHEON IE, BLACKLOCK JB, WEBER RS, DE MONTE F, MOSER RP, BYERS M, GOEPFERT H. Anterior transcranial resection of tumors of the paranasal sinuses: Surgical technique and results. NEUROSURG. 1996;38(3):471-480. (Pubitemid 26067759)
55. SHAH JP, KRAUS DH, ARBIT E, GALICICH JH, STRONG EW. Craniofacial resection for tumors involving the anterior skull base. OTOLARYNGOL. HEAD NECK SURG. 1992;106:387-393.
56. VON TUYL R, GUSSACK GS. Prognostic factors in craniofacial surgery. LARYNGOSCOPE. 1991;101(3):240-244.
57. DE GABORY L, CONSO F, KRIEF P, STOLL D. Is ethmoidal adenocarcinoma screening in employees exposed to wood dust justified? REV LARYNGOL OTOL RHINOL. 2008;129,4:219-226.
58. KLEINSASSER O, SCHROEDER HG. Adenocarcinomas of the inner nose after exposure to wood dust. ARCH OTORHINOLARYNGOL. 1988;245:1-15
59. BATSAKIS J, HOLTZ F, SUEPER R, ARBOR A. Adenocarcinoma of nasal and paranasal cavities. ARCH OTORHINOLARYNGOL. 1963;77:625-633.
60. FRANQUEMONT D, FECHNER R, MILLS S. Histologic classification of sinonasal intestinal-type adenocarcinoma. AM J SURG PATHO. 1991;15:368-375.
61. VERNET JL, KENNEL P, PILLER P, METHLIN A, WALTER P, CONRAUX C. Intestinal-type adenocarcinoma of the nasal fossae and sinuses: Histological classification, clinical aspects and pronostic assessment. REV LARYNGOL OTOL RHINOL. 1994;115:107-112.
62. FRANCHI A, GALLO O, SANTUCCI M. Clinical relevance of the histological classification of sinonasal intestinal-type adenocarcinomas. HUMAN PATHOL. 1999;30:1140-1145.
63. WU TT, BARNES L, BAKKER A, SWALSKY PA, FINKELSTEIN SD. K-ras-2 and p53 genotyping of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. MOD PATHOL. 1996;9(3):199-204.
64. KENNEDY MT, JORDAN RC, BEREAN KW, PEREZ-ORDOÑEZ B. Expression pattern of CK7, CK20, CDX-2, and villin in intestinal-type sinonasal adenocarcinoma. J CLIN PATH 2004;57:932-937.
65. KORINTH D, PACYNA-GENGELBACH M, DEUTSCHMANN N, et al. Chromosomal imbalances in wood dust-related adenocarcinomas of the inner nose and their associations with pathological parameters. J PATHOL. 2005;207:207-215
66. BOYSEN M, SOLBERG LA. Changes in the nasal mucosa of furniture workers. A pilot study. SCAND J WORK ENVIRON HEALTH 1982;8(4):273-282
67. BOYSEN M, VOSS R, SOLBERG LA. The nasal mucosa in softwood exposed furniture workers. ACTA OTOLARYNGOL 1986;101:501-508
68. WILHELMSSON B, LUNDH B. Nasal epithelium in woodwokers in the furniture industry. A histological and cytological study. ACTA OTOLARYNGOL. 1984;98:321-334
69. WILHELMSSON B, HELLQUIST H, OLOFSSON J, KLINTENBERG C. Nasal cuboidal metaplasia with dysplasia. ACTA OTOLARYNGOL. 1985;99:641-648.
70. BUSSI M, GERVASIO C-F, RIONTINO E, et al. Study of ethmoidal mucosa in a population at occupational high risk of sinonasal adenocarcinoma. ACTA OTOLARYNGOL. 2002;122(2):197-201
71. VALENTE G, FERRARI L, KERIM S, GERVASIO CF, RICCI E, MIGLIARETTI G, PIRA E, BUSSI M. Evidence of p53 immunohistochemical overexpression in ethmoidal mucosa of wood-workers. CANCER DETECTION AND PREVENTION. 2004;28:99-106.
72. WOLF J, SCHMEZER P, FENGEL D, SCHROEDER HG, SCHEITHAUER H, WOESTE P. The role of combination effects on the etiology of malignant nasal tumours in the wood-wooking industry. ACTA OTOLARYNGOL. 1998 Suppl;535:1-16.
73. TORJUSSEN W, SOLBERG LA, HØGETVEIT AC. Histological changes of the nasal mucosa in active and retired nickel workers. BR J CANCER. 1979;40(4):568-580 (Pubitemid 10190211)
74. STOSIEK P, KASPER M, MOLL R. Changes in cytokeratin expression accompany squamous metaplasia of the human respiratory epithelium. VIRCHOWS ARCH A PATHOL ANAT HISTOPATHOL. 1992;421(2):133-141
75. MOLL R, FRANKE WW, SCHILLER DL, et al. The catalogue of human cytokératins: Patterns of expression in normal epithelial, tumors, and culture cells. CELL. 1982;31:11-24.
76. MOLL R. Cytokeratins as markers of differentiation: Expression profiles in epithelia and epithelial tumors. Gustav Fisher, Stuttgart, Germany. 1993.
77. BORDENAVE L, BAREILLE R, ROUAIS F, LEFEBVRE F, AMEDEE J, BAQUEY C. Human tracheal epithelial cells in culture: A suitable model for testing the cytocompatibility of materials for endotracheal use. J. MATER. SC. MATER. MED. 1993;4:327-36.
78. MOLL R, ZIMBELMANN R, GOLDSCHMIDT MD, KEITH M, LAUFER J, KASPER M, KOCH PJ, FRANKE WW. The human gene encoding cytokeratine 20 and its expression during foetal development and in gastrointestinal carcinomas. DIFFERENTIATION. 1993;53(2):75-93.
79. BASHIR AA, ROBINSON RA, BENDA JOA, SMITH RB. Sinonasal adenocarcinoma: Immunohistochemical marking and expression of oncoproteins. HEAD NECK. 2003;25:763-771.
80. FRANCHI A, MASSI D, PALOMBA A, BIANCALANI M, SANTUCCI M. CDX-2, cytokeratine 7 and cytokeratine 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract. VIRCHOWS ARCH. 2004;445:63-67.
81. KRANE JF, O'CONNELL JT, PLICH BZ, FAQUIN W. Cytokeratin and mucin expression in intestinal-type sinonasal adenocarcinome. MOD PATH. 2000;13:814.
82. RESTO VA, KRANE JF, FAQUIN WC, LIN DT. Immunohistochemical distinction of intestinal-type sinonasal adenocarcinoma from metastatic adenocarcinoma of intestinal origin. ANN OTOL RHINOL LARYNGOL. 2006;115(1):59-64.
83. CHOI HR, STURGIS E, RASHID A, DEMONTE F, LUNA MA, BATSAKIS JG, EL-NAGGAR AK. Sinonasal adenocarcinoma: Evidence for histogenic divergence of the enteric and nonenteric phenotypes. HUM PATHOL. 2003;34:1101-1107.
84. CHU P, WU E, WEISS LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. MOD PATH 2000;13:962-972.
85. ABECASIS J, VIANA G, PISSARA C, PEREIRA T, FONSECA I, SOARES J. Adenocarcinomas of the nasal cavity and paranasal sinuses: A clinicopathological and immunohistochemical study of 14 cases. HISTOPATHOLOGY. 2004;45(3):254-259
86. MOSKALUK CA, ZHANG H, POWELL SM, CERILLI LA, HAMPTON GM, FRIERSON HF Jr. Cdx2 protéin expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. MOD PATHOL. 2003;16:913-919.
87. DE LOTT LB, MORRISON C, SUSTER S, COHN DE, FRANKEL WL. CDX2 is a useful of intestinal-type differentiation: A tissue microarray-based study of 629 tumors from various sites. ARCH PATHOL LAB MED 2005;129(9):1100-1105
88. FRANCHI A, MASSI D, BARONI G, SANTUCCI M. CDX-2 homeobox gene expression. AM J SURG PATHOL. 2003;27(10):1390-1.
89. PRALL F, NOLLAU P, NEUMAIER M, et al. CD66a (BGP) an adhesion moleculeof the carcinoembryonic antigen family, is expressed in epithelium, endothelium and myeloid cells in a wide range of normal human tissues. J HISTOCHEM CYTOCHEM 1996;44:35-41.
90. NAP M, MOLLGARD K, BURTIN P, FLEUREN GJ. Immunohistochemistry of carcino-embryonic antigen in the embryo, fetus and adult. TUMOR BIOL. 1988;9:145-153.
91. NAP M, HAMMARSTRÖM ML, BÖRMER O, et al. Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen. CANCER RES. 1992;52:2329-2339.
92. OBRINK B. CEA adhesion molecules: Multifunctional proteins with signal-regulatory properties. CURR OPIN CELL BIOL. 1997;9(5):616-626
93. BENCHIMOL S, FUKS A, JOTHY S, BEAUCHEMIN N, SHIROTA K, STANNERS C. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. CELL. 1989 april;57(2):327-334.
94. HAMMARSTRÖM S. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. CANCER BIOLOGY. 1999;9:67-81.
95. MCKINNEY CD, MILLS SE, FRANQUEMONT DW. Sinonasal intestinal-type adenocarcinoma: Immunohistochemical profile and comparison with colonic adenocarcinoma. MOD PATHOL. 1995;8(4):421-426
96. CASTILLO C, BUOB D, MORTUAIRE G, CHEVALIER D, AUBERT S, COPIN MC, LEROY X. Signet-ring cell adenocarcinoma of sinonasal tract: An immunohistochemical study of the mucus profile. ARCH PATHOL LAB MED. 2007;131(6):961-964
97. PERRONE F, OGGIONNI M, BIRINDELLI S, SUARDI S, TABANO S, ROMANO R, MOIRAGHI ML, BIMBI G, QUATTRONE P, CANTU G, PIEROTTI MA, LICITRA L, PILOTTI S. TP53, P14ARF, P16INK4A and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. INT J CANCER. 2003;105:196-203.
98. YOM SS, RASHID A, ROSENTHAL DI, ELLIOTT DD, HANNA EY, WEBER RS, EL-NAGGAR AK. Genetic analysis of sinonasal adenocarcinoma phenotypes: Distinct alterations of histogenetic significance. MOD PATHOL. 2005;18:315-319.
99. OZOLEK JA, HUNT JL. Tumor suppressor gene alterations in respiratory epithelial adenomatoid hamartoma (REAH): Comparison to sinonasal adenocarcinoma and inflamed sinonasal mucosa. AM J SURG PATHOL. 2006;30:1576-1580.
100. KORINEK V, BARKER N, MORIN PJ et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. SCIENCE. 1997;275(5307):1784-1787
101. MORIN PJ, SPARKS AB, KORINEK V, BARKER N, CLEVERS H, VOGELSTEIN B, KINZLER KW. Activation of beta-catenin-Tcf signaling in colon cancer by mutations of beta-catenin or APC. SCIENCE. 1997;275(5307):1787-1790
102. FRATTINI M, PERRONE F, SUARDI S, BALESTRA D, CARAMUTA S, COLOMBO F, LICITRA L, CANTÙ G, PIEROTTI M, PILOTTI S. Phenotype-genotype correlation: Challenge of intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. HEAD NECK 2006;28:909-915.
103. PÉREZ P, DOMINGUEZ O, GONZÁLEZ S, GONZÁLEZ S, TRIVIÑO A, SUÁREZ C. Ras gene mutations in ethmoid sinus adenocarcinoma: Prognostic implications. CANCER. 1999 Jul 15;86(2):255-264
104. BOS JL, FEARON ER, HAMILTON SR, VERLAAN-DE VRIES M, VAN BOOM JH, VAN DER EB AJ, VOLGENSTEIN B. Prevalence of ras gene mutations in human colorectal cancers. NATURE. 1987;327:293-297.
105. SABER AT, NIELSEN LR, DICTOR M, HAGMAR L, MIKOCZY Z, WALLIN H. K-ras mutations in sinonasal adenocarcinoma in patients occupationnally exposed to wood ou leather dust. CANCER LETTERS 1998;126:59-65.
106. JANSSEN KP, EL MARJOU F, PINTO D, SASTRE X, ROUILLARD D, FOUQUET C, SOUSSI T, LOUVARD D, ROBINE S. Targeted expression of oncogenic K-ras in intestinal epithelium causes spontaneous tumorigenesis in mice. GASTRO ENTEROLOGY. 2002;123(2):492-504.
107. GALLO O, FRANCHI A, FINI-STORCHI I, CILENTO G, BODDI V, BOCCUZZI S, URSO C. Prognostic significance of c-erbB-2 oncoprotein expression in intestinal-type adenocarcinoma of the sinonasal tract. HEAD NECK. 1998;20:224-231
108. PEREZ-ORDONEZ B, HUYNH NN, BEREAN KW, JORDAN RCK. Expression of mismatch repair proteins, beta catenin, and E Cadherin in intestinal-type sinonasal adenocarcinoma. J CLIN PATHOL. 2004 Oct;57(10):1080-1083
109. VALENTE G, MAMO C, BENA A, et al. Prognostic significance of microvessel density and vascular endothelial growth factor expression in sinonasal carcinomas. HUM PATHOL. 2006;37:391-400.
110. DE GABORY L, DEMINIÈRE C, STOLL D. Expression immunohistochimique de l'ACE, de l'UEA-I et du Ki-67 dans les papillomes inversés naso-sinusiens. REV LARYNGOL OTOL RHINOL. 2008;129,3:159-165.